BridgeMD
New treatment option for Clinical High Risk for Psychosis (CHR)
Official title Experience of UHR and PEP Individuals During Mindfulness: a Qualitative Phenomenological Study
ClinicalTrials.gov ID: NCT07499934
What this study is testing
- What it's testing
- The goal of this qualitative study is to explore and describe the lived experiences of individuals at ultra-high risk (UHR) or first episode of psychosis (FEP) who have participated in a group-based mindfulness-based intervention. Secondary objectives include identifying potential adverse effects of a group-based mindfulness-based intervention among UHR or FEP.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 to 30
You may be able to join if
- People aged between 15 and 30 years who meet the criteria for UHR or PEP status on the CAARMS scale and have a social functional impact (SOFAS score...
You likely can't join if
- \- Previous episode of schizophrenia, schizoaffective disorder, or bipolar disorder
- Previous antipsychotic treatment for more than 12 months
- Organic mental disorder or intellectual disability
- Serious suicide/homicidal risk (but admissible if this risk has been resolved)
- Insufficient French language skills
- Adult unable to give consent and not under legal guardianship
See the full eligibility criteria
- People aged between 15 and 30 years who meet the criteria for UHR or PEP status on the CAARMS scale and have a social functional impact (SOFAS score less than 50 or a decrease of more than 30% in the score)
- \- Previous episode of schizophrenia, schizoaffective disorder, or bipolar disorder
- Previous antipsychotic treatment for more than 12 months
- Organic mental disorder or intellectual disability
- Serious suicide/homicidal risk (but admissible if this risk has been resolved)
- Insufficient French language skills
- Adult unable to give consent and not under legal guardianship
- Protective measure (guardianship/conservatorship/judicial protection) or under judicial supervision
- Person deprived of liberty by judicial or administrative decision (including actual involuntary hospitalization)
- Persons in a life-threatening emergency
- Not affiliated with a social security scheme
- Minors without parental authorization
- Person who refused the audio recording of the interview
The study team makes the final eligibility decision.
Where it's taking place
- Laxou, France
- Vitry-le-François, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 15 years to 30 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Laxou, France; Vitry-le-François, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.